'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer; Patient's response was predicted by test for mutant protein in tumor cells
Thursday, October 28, 2010 - 08:31
in Health & Medicine
A new oral drug caused dramatic shrinkage of a patient's rare, aggressive form of soft-tissue cancer that was driven by an abnormally activated protein, researchers report.